Chih-Wei Wu Selected Research

Chih-Wei Wu Research Topics

Disease

7	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2019
4	Hypertension (High Blood Pressure) 11/2022 - 01/2013
4	Dyspnea (Shortness of Breath) 01/2022 - 09/2018
4	Neoplasms (Cancer) 01/2019 - 02/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2018
2	Infections 07/2020 - 03/2014
2	Neuroinflammatory Diseases 01/2020 - 11/2019
2	Inflammation (Inflammations) 11/2019 - 01/2011
2	Ischemia 10/2016 - 07/2016
2	Wounds and Injuries (Trauma) 04/2015 - 01/2010
2	Hyperemia 09/2014 - 10/2011
2	Alzheimer Disease (Alzheimer's Disease) 12/2004 - 04/2003
1	Tachycardia (Tachyarrhythmias) 11/2022
1	Heart Failure 11/2022
1	Sleepiness 01/2022
1	Peripheral Arterial Disease 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 10/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 03/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Pulmonary Tuberculosis 08/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Chemical Burns (Chemical Burn) 09/2018
1	Burns 09/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Insulin Resistance 01/2018
1	Gliosis 01/2018
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Adenocarcinoma 10/2017
1	Weight Loss (Weight Reduction) 12/2016
1	Infarction (Infarctions) 10/2016
1	Osteoradionecrosis 09/2016
1	Seroma 09/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2016
1	Contracture 09/2016
1	Cicatrix (Scar) 09/2014
1	Lymphedema (Milroy Disease) 03/2014
1	Virus Diseases (Viral Diseases) 03/2014
1	Adenocarcinoma of Lung 01/2014
1	Necrosis 02/2012
1	Shock 07/2011

Drug/Important Bio-Agent (IBA)

6	FructoseIBA 01/2022 - 01/2014
4	Oxygen (Dioxygen)IBA 01/2022 - 09/2018
3	Mitochondrial DNA (mtDNA)IBA 11/2022 - 01/2018
3	Pioglitazone (Actos)FDA Link 01/2020 - 01/2017
2	PPAR gammaIBA 11/2022 - 01/2018
2	Clostridium perfringens epsilon-toxinIBA 09/2020 - 01/2019
2	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 07/2016 - 09/2014
1	Milrinone (Primacor)FDA LinkGeneric 11/2022
1	CatecholaminesIBA 11/2022
1	esmolol (Brevibloc)FDA LinkGeneric 11/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2022
1	mitochondrial transcription factor AIBA 11/2022
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2022
1	SmokeIBA 01/2022
1	TOPSIBA 01/2022
1	AsbestosIBA 10/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	vasectrin II (VS II)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 07/2020
1	SteroidsIBA 07/2020
1	AntioxidantsIBA 01/2020
1	Nucleic AcidsIBA 08/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Explosive Agents (Explosives)IBA 09/2018
1	SynucleinsIBA 01/2018
1	2-tert-butylhydroquinone (tert-butylhydroquinone)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	HydrogelsIBA 12/2016
1	Peptides (Polypeptides)IBA 12/2016
1	Isoflurane FDA LinkGeneric 10/2016
1	Saline SolutionIBA 10/2016
1	CarrageenanIBA 03/2014
1	Antiviral Agents (Antivirals)IBA 03/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2013
1	Conditioned Culture MediaIBA 02/2012
1	Ethanol (Ethyl Alcohol)IBA 07/2011
1	hydroxide ionIBA 07/2011
1	Neuroprotective AgentsIBA 01/2011

Therapy/Procedure

4	Mammaplasty (Breast Reconstruction) 01/2019 - 09/2014
2	Acupuncture Points (Acupuncture Point) 01/2021 - 01/2020
2	Perforator Flap 04/2015 - 10/2011
2	Debridement 04/2015 - 09/2014
2	Phacoemulsification 01/2008 - 10/2006
1	Nebulizers and Vaporizers (Inhaler) 03/2021
1	Therapeutics 03/2021
1	Length of Stay 07/2020
1	Acupuncture Therapy 01/2020
1	Radiotherapy 01/2019
1	Mechanical Ventilators (Ventilator) 01/2019
1	Segmental Mastectomy (Lumpectomy) 01/2019
1	Free Tissue Flaps 09/2018
1	Mandibular Reconstruction 09/2016
1	Lab-On-A-Chip Devices 03/2014
1	Lymph Node Excision (Lymph Node Dissection) 03/2014